Navigation Links
Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious 'Outstanding Contribution' Award
Date:3/3/2011

WASHINGTON, March 3, 2011 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA), which represents the world's leading generic drug manufacturers and suppliers, has honored Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt with the industry's prestigious "Outstanding Contribution" Award.  

(Photo: http://photos.prnewswire.com/prnh/20110303/DC58687)

The award was presented at GPhA's Annual Meeting in Orlando, Florida.  PCMA represents the nation's PBMs which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

"I'm honored to receive this award and proud to stand with GPhA, employers, and consumer groups in the fight for affordable prescription drugs," said PCMA President and CEO Mark Merritt.  

Proven PBM tools and techniques – including increasing the use of generic medications – has helped result in drug spending during the 2007-2009 period growing at its slowest annual rates in more than 40 years.   Research released by the Congressional Budget Office (CBO) found that the use of generic medications rather than brand-name medications in Medicare Part D saved beneficiaries and the program about $33 billion in 2007 with an additional $14 billion in savings expected as first-time generics enter the market through 2012. Over the past decade, generic medications have helped save the United States health care system $824 billion.  

The Generic Pharmaceutical Association (GPhA) represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 75 percent of the prescriptions dispensed in the U.S. but consume just 22 percent of the total drug spending.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Neurontin® Capsules
2. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
3. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
4. PCMA: Generics, Mail-Service Pharmacy Recognized as Ways to Reduce Costs for TRICARE Program
5. Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013
6. Mylan Launches First Generic Version of Vfend® Tablets
7. PCMA: Some Drugmakers Lobbying to Limit E-Prescribing of Generics, Drug Safety Checks
8. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
9. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
10. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
11. Mylans Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):